Additionally, the predicted thinner snowpacks may increase the frequency of injuries due to trauma, such as a buried skier striking a rock or tree. Avalanches on the planet Mars
See also
Related flows
Avalanche disasters
1999 Galtür avalanche
Montroc
2012 Gayari Sector avalanche

References
Bibliography
McClung, David. Snow Avalanches as a Non-critical, Punctuated Equilibrium System: Chapter 24 in Nonlinear Dynamics in Geosciences, A.A. Tsonsis and J.B. Elsner (Eds. ), Springer, 2007
Daffern, Tony: Avalanche Safety for Skiers, Climbers and Snowboarders, Rocky Mountain Books, 1999, ISBN 0-921102-72-0
Billman, John: Mike Elggren on Surviving an Avalanche. Skiing magazine February 2007: 26. McClung, David and Shaerer, Peter: The Avalanche Handbook, The Mountaineers: 2006. 978-0-89886-809-8
Tremper, Bruce: Staying Alive in Avalanche Terrain, The Mountaineers: 2001. ISBN 0-89886-834-3
Munter, Werner: Drei mal drei (3x3) Lawinen. Risikomanagement im Wintersport, Bergverlag Rother, 2002. ISBN 3-7633-2060-1 (in German) (partial English translation included in PowderGuide: Managing Avalanche Risk ISBN 0-9724827-3-3)
Michael Falser: Historische Lawinenschutzlandschaften: eine Aufgabe für die Kulturlandschafts- und Denkmalpflege In: kunsttexte 3/2010, unter: Historische Lawinenschutzlandschaften: eine Aufgabe für die Kulturlandschafts- und Denkmalpflege

Notes
External links

 Media related to Avalanche chute at Wikimedia Commons

The Avalanche Education Project
Surviving an Avalanche – A guide for children and youth
Avalanche Defense Photographs
Avalanche Canada
Canadian Avalanche Association Archived 21 October 2020 at the Wayback Machine
Colorado Avalanche Information Center
Center for Snow and Avalanche Studies
EAWS – European Avalanche Warning Services
Directory of European avalanche services
Avalanches collected news and commentary at The New York Times
Swiss Federal Institute for Snow and Avalanche Research
Scottish Avalanche Information Service
Chisholm, Hugh, ed. (1911). "Avalanche" . Encyclopædia Britannica (11th ed.). Cambridge University Press.
Cefuroxime, sold under the brand name Zinacef among others, is a second-generation cephalosporin antibiotic used to treat and prevent a number of bacterial infections. These include pneumonia, meningitis, otitis media, sepsis, urinary tract infections, and Lyme disease. It is used by mouth or by injection into a vein or muscle.Common side effects include nausea, diarrhea, allergic reactions, and pain at the site of injection. Serious side effects may include Clostridium difficile infection, anaphylaxis, and Stevens–Johnson syndrome. Use in pregnancy and breastfeeding is believed to be safe. It is a second-generation cephalosporin and works by interfering with a bacterias ability to make a cell wall resulting in its death.Cefuroxime was patented in 1971, and approved for medical use in 1977. It is on the World Health Organizations List of Essential Medicines. In 2017, it was the 342nd most commonly prescribed medication in the United States, with more than 800 thousand prescriptions. Medical uses
Cefuroxime is active against many bacteria including susceptible strains of Staphylococci and Streptococci, as well as a range of gram negative organisms. As with the other cephalosporins, it is susceptible to beta-lactamase, although as a second-generation variety, it is less so. Hence, it may have greater activity against Haemophilus influenzae, Neisseria gonorrhoeae, and Lyme disease. Unlike other second-generation cephalosporins, cefuroxime can cross the blood-brain barrier.A systematic review found high quality evidence that injecting the eye with cefuroxime after cataract surgery will lower the chance of developing endophthalmitis after surgery. Side effects
Cefuroxime is generally well tolerated, and its side effects are usually transient.